Menopause and Mood

Depression is a disabling condition that often leads to significant burden. Women are more vulnerable to depression during reproductive-related “windows of vulnerability” such as the menopause transition and early postmenopausal years. This heightened vulnerability can be attributed, at least in part, to the neuromodulatory effects of estrogen on mood and cognition and the exposure to rapid fluctuations of estradiol levels during midlif e years. The management of midlife depression can be challenging due to the presence and severity of other complaints such as vasomotor symptoms and sleep disturbances. Psychopharmacologic, behavioral, and hormonal interventions should be part of the treatment armamentarium.
Source: The Psychiatric Clinics of North America - Category: Psychiatry Authors: Source Type: research